Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus

Documenti analoghi

• Efficacy of DNA and Fowlpox Virus Priming/Boosting Vaccines for Simian/Human Immunodeficiency Virus
  di: Dale, C. J., et al.
  Pubblicazione: (2004)
• Induction of Neutralizing Antibodies to T-Cell Line-Adapted and Primary Human Immunodeficiency Virus Type 1 Isolates with a Prime-Boost Vaccine Regimen in Chimpanzees
  di: Zolla-Pazner, Susan, et al.
  Pubblicazione: (1998)
• Different Levels of Immunogenicity of Two Strains of Fowlpox Virus as Recombinant Vaccine Vectors Eliciting T-Cell Responses in Heterologous Prime-Boost Vaccination Strategies
  di: Cottingham, Matthew G., et al.
  Pubblicazione: (2006)
• Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens
  di: Tan, Wendy G., et al.
  Pubblicazione: (2017)
• Induction of Both Cellular and Humoral Immunity following a Rational Prime-Boost Immunization Regimen That Incorporates Recombinant Ovine Atadenovirus and Fowlpox Virus
  di: Fraser, Cara K., et al.
  Pubblicazione: (2010)